Taxoprexin

DRUG5 trials

Sponsors

American Regent, Inc.

Conditions

Cancer of the LiverMalignant MelanomaMetastatic MelanomaNon-Small Cell Lung Cancer

Phase 2

Taxoprexin® Treatment for Advanced Eye Melanoma

CompletedNCT00244816

American Regent, Inc.Metastatic Melanoma

Start: 2005-10-31End: 2008-06-30Updated: 2025-10-23

Taxoprexin Treatment for Advanced Skin Melanoma

CompletedNCT00249262

American Regent, Inc.Metastatic Melanoma

Start: 2005-10-31End: 2007-04-30Updated: 2025-09-26

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

TerminatedNCT00422877

American Regent, Inc.Cancer of the Liver

Start: 2007-01-31End: 2008-03-31Updated: 2025-10-16

Phase 3

Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma

TerminatedNCT00087776

American Regent, Inc.Malignant Melanoma

Start: 2002-12-06End: 2007-10-27Updated: 2025-07-23

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

CompletedNCT00243867

American Regent, Inc.Non-Small Cell Lung Cancer

Start: 2005-11-30End: 2008-08-31Updated: 2025-08-01